ChatGPT publisher, OpenAI, has teamed up with a longevity startup to develop an artificial intelligence model dedicated to the study of stem cells. Their aim is to extend the normal human lifespan by up to 10 years.
OpenAI has developed a new artificial intelligence model in collaboration with Retro Biosciences. It aims to extend life expectancy by studying Yamanaka factors, a set of proteins capable of reprogramming adult cells into pluripotent stem cells. This exclusive model, GPT-4b micro, has been designed to pave the way not only for the regeneration of different cell types, but also for the creation of customised organs in the best-case scenario.
